Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Vilazodone for the Treatment of Major Depressive Disorder: Focusing on Its Clinical Studies and Mechanism of Action

Authors
Wang, Sheng-MinHan, ChangsuLee, Soo-JungPatkar, Ashwin A.Masand, Prakash S.Pae, Chi-Un
Issue Date
4월-2015
Publisher
KOREAN NEUROPSYCHIATRIC ASSOC
Keywords
Vilazodone; Antidepressant; Novel mechanism; Efficacy; Safety
Citation
Psychiatry Investigation, v.12, no.2, pp.155 - 163
Indexed
SCIE
SSCI
SCOPUS
KCI
Journal Title
Psychiatry Investigation
Volume
12
Number
2
Start Page
155
End Page
163
URI
https://scholar.korea.ac.kr/handle/2021.sw.korea/93913
DOI
10.4306/pi.2015.12.2.155
ISSN
1738-3684
Abstract
We tried to review and update clinical and preclinical studies evaluating vilazodone's role as an antidepressant for patients with major depressive disorder (MDD). In terms of its mechanism of actions, we sought to elaborate them mainly through predinical animal studies. A data search was conducted in November 1,2013, using the key terms "vilazodone" or "Viibryd," in PubMed and Medline databases. All published and unpublished studies are included and citations from publications were also reviewed for additional references. Five unpublished, phase-II and two pivotal published phase-III clinical trials with nearly identical design (8-week, double-blind, randomized, and placebo-controlled) investigated efficacy of vilazodone, were found for the treatment of patients with MDD. Two post-hoc studies and one long-term open study were also included. Data were thoroughly reviewed to incorporate the pharmacology, action mechanism, efficacy and safety for the vilazodone in the treatment of major depressive disorder. Vilazodone is an antidepressant with novel mechanism of action because its chemical structure is unrelated to conventional antidepressant, and it has a selective serotonin (5-HT) reuptake inhibitor and 5-HT1A receptor partial agonist profile. Vilazodone is an effective and safe treatment option with its novel action mechanisms for patients with depression. Its putative benefits compared with other antidepressants must be thoroughly studied in adequately-powered and well-designed future clinical trials.
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Medicine > Department of Medical Science > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Han, Chang su photo

Han, Chang su
의과대학 (의학과)
Read more

Altmetrics

Total Views & Downloads

BROWSE